D B Zorov Selected Research

D B Zorov Research Topics

Disease

16	Ischemia 12/2019 - 01/2005
4	Inflammation (Inflammations) 12/2020 - 08/2014
4	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2020 - 08/2015
4	Brain Ischemia (Cerebral Ischemia) 09/2017 - 12/2008
3	Renal Insufficiency (Renal Failure) 12/2016 - 09/2010
3	Rhabdomyolysis 09/2012 - 01/2011
2	Fibrosis (Cirrhosis) 11/2023 - 01/2023
2	Brain Injuries (Brain Injury) 10/2019 - 09/2017
2	Pyelonephritis 01/2019 - 11/2016
2	Infarction (Infarctions) 09/2017 - 12/2008
2	Ototoxicity 07/2013 - 06/2012
2	Wounds and Injuries (Trauma) 09/2012 - 02/2009
2	Cardiac Arrhythmias (Arrythmia) 06/2011 - 12/2008
2	Stroke (Strokes) 06/2011 - 12/2008
2	Hypoglycemia (Reactive Hypoglycemia) 09/2010 - 05/2007
1	Reperfusion Injury 11/2023
1	Septic Shock (Toxic Shock Syndrome) 01/2023
1	Ureteral Obstruction 01/2023
1	Cytokine Release Syndrome 01/2023
1	Shock 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 06/2020
1	Hypoxia (Hypoxemia) 01/2016
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2016
1	Bipolar Disorder (Manic Depressive Psychosis) 08/2014
1	Urinary Retention 05/2013
1	Hearing Loss (Hearing Impairment) 06/2012
1	Alzheimer Disease (Alzheimer's Disease) 12/2011
1	Myocardial Infarction 06/2011
1	Cataract (Cataracts) 06/2011
1	Osteoporosis 06/2011
1	Solitary Kidney 01/2011

Drug/Important Bio-Agent (IBA)

8	AntioxidantsIBA 01/2023 - 09/2008
4	LithiumIBA 01/2016 - 09/2008
4	IonsIBA 08/2014 - 05/2007
4	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2013 - 01/2005
3	CytokinesIBA 01/2023 - 11/2016
3	Gentamicins (Gentamicin)FDA LinkGeneric 07/2013 - 01/2011
2	CationsIBA 01/2023 - 09/2012
2	LipopolysaccharidesIBA 01/2023 - 11/2016
2	Neuroprotective AgentsIBA 12/2020 - 08/2015
2	NitrogenIBA 12/2019 - 01/2005
2	Urea (Carbamide)FDA LinkGeneric 12/2019 - 09/2012
2	CreatinineIBA 12/2019 - 09/2012
2	Histones (Histone)IBA 11/2016 - 06/2011
2	Lithium ChlorideIBA 01/2016 - 07/2009
2	Therapeutic UsesIBA 08/2015 - 05/2013
2	RhodaminesIBA 09/2012 - 09/2012
2	PlastoquinoneIBA 09/2012 - 01/2011
2	Insulin (Novolin)FDA Link 09/2010 - 09/2008
2	ChloridesIBA 07/2009 - 02/2009
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 11/2023
1	Hydroxyproline (4 Hydroxyproline)IBA 11/2023
1	Malate Dehydrogenase (Dehydrogenase, Malate)IBA 11/2023
1	Oxidoreductases (Dehydrogenase)IBA 11/2023
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2023
1	Progesterone FDA LinkGeneric 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 12/2019
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	Sirolimus (Rapamycin)FDA Link 12/2019
1	TOR Serine-Threonine KinasesIBA 12/2019
1	Lipocalin-2IBA 12/2019
1	Fibroins (Fibroin)IBA 10/2019
1	Biocompatible Materials (Biomaterials)IBA 10/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	EndotoxinsIBA 06/2018
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2018
1	AntigensIBA 06/2018
1	zolazepam drug combination tiletamineIBA 09/2017
1	Chloral HydrateIBA 09/2017
1	Anesthetics (Anesthetic Agents)IBA 09/2017
1	Nitroarginine (NG Nitro L Arginine)IBA 12/2016
1	IsotopesIBA 11/2016
1	Protective AgentsIBA 11/2016
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2016
1	Amyloid (Amyloid Fibrils)IBA 10/2014
1	Peptides (Polypeptides)IBA 10/2014
1	Amyloid beta-PeptidesIBA 10/2014
1	SaltsIBA 08/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2013
1	AminoglycosidesIBA 07/2013
1	GalactosidasesIBA 06/2011
1	LipidsIBA 01/2011
1	Cytochromes c (Cytochrome c)IBA 01/2011
1	Erythropoietin FDA Link 01/2011
1	Glutamine (L-Glutamine)FDA Link 09/2010
1	N-Methylaspartate (NMDA)IBA 09/2010
1	Serine (L-Serine)FDA Link 09/2010
1	EnzymesIBA 09/2010
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2008
1	10-(6'-plastoquinonyl) decylrhodamine 19IBA 12/2008
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2008

Therapy/Procedure

4	Therapeutics 12/2020 - 12/2011
3	Intraperitoneal Injections 09/2012 - 12/2008
1	Ketogenic Diet 11/2023
1	Caloric Restriction 11/2023
1	Transplantation 10/2019
1	Anesthesia 09/2017
1	Intra-Arterial Injections 08/2015
1	Aftercare (After-Treatment) 06/2011